News

The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...
Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu strains ...
Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...
Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace ...
Moderna will merge its technology and HR teams departments, thanks to their increasing reliance on AI and ongoing OpenAI ...
Moderna’s Chief People & Digital Officer, Tracey Franklin, has become the latest high-profile executive to reveal how agentic ...
We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger ...
The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.